Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Regulus Therapeutics (RGLS)

1.02 +0.10 (+11.48%)

6/26/2017  4:00pm

Open:

0.94

Pre. Close:

0.92

High:

1.04

Low:

0.92

Volume:

738,606

Market Cap:

54.25M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.06 - 1.08

1.08 - 1.11

Low:

0.87 - 0.89

0.89 - 0.92

Close:

0.98 - 1.01

1.01 - 1.05

Technical analysis  (as of: 2017-06-26 11:36:11 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 1.54     One year: 1.87

Support:

Support1: 0.86    Support2: 0.72

Resistance:

Resistance1: 1.32    Resistance2: 1.60

Pivot:

1.17

Moving Averages:

MA(5): 0.96     MA(20): 1.23

MA(100): 1.36     MA(250): 2.33

MACD:

MACD(12,26): -0.14     Signal(12,26,9): -0.12

%K %D:

%K(14,3): 15.54     %D(3): 13.86

RSI:

RSI(14): 38.13

52-Week:

High: 5.75  Low: 0.86  Change(%): -80.7

Average Vol(K):

3-Month: 856  10-Days 1207

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
RGLS has closed above bottom band by 34.6%. Bollinger Bands are 59.1% wider than normal. The large width of the bands suggest high volatility as compared to RGLS's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Mon, 26 Jun 2017 18:22:30 GMT
Another motive To buy these stock: Regulus Therapeutics Inc. (RGLS), Ollie's ...

Mon, 12 Jun 2017 10:52:30 GMT
Regulus Announces Pipeline Updates and Advancements

Mon, 26 Jun 2017 21:30:03 GMT
Regulus Therapeutics Inc. (RGLS) Soars 11.48% on June 26

Thu, 08 Jun 2017 06:00:00 GMT
Aptuit anuncia un acuerdo de proveedor estratégico con Regulus Therapeutics

Thu, 04 May 2017 20:26:15 GMT
BRIEF-Regulus reports Q1 revenue $100000

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

53.18

Shares Float (M)

36.25

% Held by Insiders

42.92

% Held by Institutions

65.50

Shares Short (K)

3830

Shares Short Prior Month (K)

4900

Stock Financials

EPS

-1.520

EPS Est. Current Year

-1.350

EPS Est. Next Year

-0.890

EPS Est. Next Quarter

-0.270

Forward EPS

-0.889

Book Value (p.s.)

0.730

PEG Ratio

-0.03

Profit Margin

Operating Margin

-11039.70

Return on Assets (ttm)

-47.9

Return on Equity (ttm)

-110.5

Qtrly Rev. Growth

-96.3

Gross Profit (p.s.)

0.022

Sales Per Share

EBITDA (p.s.)

-1.453

Qtrly Earnings Growth

Operating Cash Flow (M)

-66.63

Levered Free Cash Flow (M)

-37.56

FoxReading.com

Valuation

P/E

-0.67

P/E Growth Ratio

0.11

P/BV

1.40

P/S

5424359936.00

P/CF

-0.81

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.